(Q33792972)

29 July 2017

1 reference

title

Assessment of animal models for MS and demyelinating disease in the design of rational therapy (English)

1 reference

29 July 2017

main subject

demyelinating disease

1 reference

Steinman L

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

24

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

511-514

1 reference

The development of Cop 1 (Copaxone), an innovative drug for the treatment of multiple sclerosis: personal reflections

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

The Neuro-Paralytic Accidents of Anti-Rabies Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2800%2981107-1

7 January 2021

10.1016/S0896-6273(00)81107-1

Identifiers

DOI

1 reference

29 July 2017

1 reference